Main Components of Liquid Biopsy are Greater than it Seems?
Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 1, Issue 1
Abstract
Long time ago it was wrongly thought that tumor genes and cells are only existence in the exact tumor site. In spite of the fact of the hypothesis that circulating tumor cells (CTCs) are a fundamental prerequisite to metastasis ( first projected in the 1896 by Thomas Ashworth, an Australian pathologist, ) and the presence of cfDNA report in human plasma by Mandel and Metals in 1948, liquid biopsy were totally ignored till 1977. In 1977, researchers made the novel observation that cancer patients carried cell-free DNA in their peripheral blood which was Initial progress on further of liquid biopsy. Without a doubt, significant progress was not made until recent years with the advent of Next Generation Sequencing (NGS) technology, which significantly improved the sensitivity and specificity of ctDNA detection. Interestingly, research in this field of liquid biopsy has entered a “golden age” in which the huge potential of liquid biopsy main components including CTCs, cfDNA and exosomes make tumor diagnosis and treatment much clearer than before. Liquid biopsy tests are fast traction as a viable substitute to traditional diagnostic tests for cancer. It has the potential to facilitate detect cancer at earlier stages, present a less-expensive and less-invasive way to monitor patients throughout treatment, and can help doctors make better decisions about which drugs are the best fit for personal patients.
Authors and Affiliations
Fatemeh Khatami, Seyed Mohammad Tavangar
Keywords
Related Articles
- EP ID EP582998
- DOI 10.32474/OAJOM.2018.01.000102
- Views 98
- Downloads 0
Pilomatricoma Localized in the Arm: A Rare Case Report
A pilomatricoma is a rare, benign skin tumour originating from the hair follicle cells. It accounts for 0.15 of skin tumours is. It usually involves the head and neck region. The definitive diagnosis is based on histolog...
Acute Erythroblastic Leukemia Revealed by Dermatological Manifestations
Acute erythroblastic leukemia is characterized by the proliferation of a predominant erythrocyte population on other lineages. Cutaneous manifestations remain rare and misleading, making the diagnosis of difficult to sus...
A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers' Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy
In the current study, we have experimentally and comparatively investigated and compared malignant human common cancers' cells, tissues and tumors such as Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometri...
Central Nervous System Manifestation of Multiple Myeloma: A Case Report
Multiple myeloma accounts for <1% of all malignancies and Central nervous system (CNS) manifestation of multiple myeloma (MM) is rare. Multiple myelomais characterized by malignant transformation of plasma cells that pro...
Quality of Life in Oncological Patient at the End of Life
Cancer is one of the diseases that have the greatest impact on the quality of life of its patients, either because of the real burden of the disease or because of all the myths involved in its diagnosis. The objective of...